Mesenchymal Stem Cell (MSC) Exosomes in Osteoarthritis: Chondrocyte Repair and Cartilage Regeneration

🩺
Medically Reviewed by Valley Clinic Editorial & Biotechnology Advisory Board
Compliant with clinical cGMP, NIH guidelines, and peer-reviewed pharmacology literature.

Articular cartilage possesses limited intrinsic self-healing capacity due to its avascular and aneural nature. Emerging cell-free regenerative therapies utilizing Mesenchymal Stem Cell (MSC) exosomes offer targeted biological repair without the complications of whole-cell transplantation.

Exosome Paracrine Signaling Mechanisms

Extracellular vesicles (30–150 nm) secreted by umbilical cord and bone marrow-derived MSCs deliver therapeutic molecular cargo directly to stressed chondrocytes:

  • MicroRNAs (miR-140-5p, miR-26a-5p): Inhibit matrix-degrading enzymes ADAMTS5 and MMP-13, halting cartilage degradation.
  • Transforming Growth Factor-Beta (TGF-β): Upregulates type II collagen (COL2A1) and aggrecan synthesis.
  • Anti-Inflammatory Cytokines (IL-10, IL-1RA): Neutralize synovial inflammation and blunt pain nociception.